KDIGO Anemia Guidelines: An Interview

The prevalence of anemia is high in people with chronic kidney disease (CKD) and increases as the disease advances. The Kidney Disease Outcomes Quality Initiative (KDOQI) convened a work group to review the Kidney Disease: Improving Global Outcomes (KDIGO) 2026 clinical practice guideline for the management of anemia in CKD.  A recent KDOQI Commentary by Jalal et al in AJKD presents recommendations and practice points from the KDIGO guideline, followed by a commentary and brief notes on clinical utility, implementation, and challenges.

Box 1 from Jalal et al, © National Kidney Foundation.

AJKDBlog’s Interviews Editor Timothy Yau chatted with authors Monique E. Cho and Jay Wish about the perspectives provided in the Commentary.

If the embedded player above doesn’t work, please click here to watch the video interview. Special thanks to Drs. Cho and Wish for their time and insight!

To view this KDOQI Commentary by Jalal et al [Subscription Required], please visit AJKD.org:

Title: KDOQI US Commentary on the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in CKD
Authors: Diana I. Jalal, Nisha Bansal, Monique E. Cho, Steven Fishbane, Orlando M. Gutierrez, Csaba P. Kovesdy, Abhijit Kshirsagar, Bruce Spinowitz, Jay Wish
DOI: 10.1053/j.ajkd.2026.03.036

 

 

Leave a Reply